Yes the lack of a vitiligo update is particularly frustrating. They announced the first patient in October last year. Since then the most we've heard is that it's ongoing and Lachlan and co shared a chuckle at the half year how they constantly get hit with requests for an update. He did suggest October this year was perhaps possible for recruitment to finish without sounding particularly confident. Clinical trials website not updated since October 23. If you don't want to have to spend too much on a buyback why not stoke the fire of the one serious growth driver you're apparently 100% committed to? It's not a secret you're running a Vitiligo trial. It's been going for six months, why not show it's on track and something the market should be starting to get excited about???
- Forums
- ASX - By Stock
- CUV
- Ann: Change to executive management
Ann: Change to executive management, page-8
Featured News
Add CUV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.63 |
Change
0.120(0.89%) |
Mkt cap ! $682.3M |
Open | High | Low | Value | Volume |
$13.55 | $13.77 | $13.43 | $581.2K | 42.76K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 248 | $13.62 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.64 | 1 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 248 | 13.620 |
1 | 156 | 13.560 |
1 | 100 | 13.410 |
2 | 107 | 13.400 |
1 | 100 | 13.390 |
Price($) | Vol. | No. |
---|---|---|
13.770 | 193 | 1 |
13.790 | 193 | 1 |
13.800 | 193 | 1 |
13.820 | 193 | 1 |
13.880 | 800 | 2 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online